On this page
CASR
calcium sensing receptor
The CASR gene encodes the calcium-sensing receptor, a protein crucial for monitoring and regulating calcium levels in the blood and maintaining mineral homeostasis. The CASR gene provides the blueprint for the calcium-sensing receptor (CaSR) protein, which plays a central role in sensing and responding to changes in circulating calcium.
CASR is located on the long (q) arm of chromosome 3, at band 3q13.33-q21.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 3 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The CASR gene, or calcium sensing receptor gene, contains the genetic instructions for producing the calcium-sensing receptor (CaSR) protein. This protein acts as a key regulator of calcium homeostasis within the body, responding to extracellular calcium levels.
Its primary role involves modulating the release of parathyroid hormone (PTH) from the parathyroid glands and influencing calcium handling by the kidneys. Dysregulation of CASR function can lead to various conditions characterised by abnormal calcium levels.
What the gene does
The CaSR protein, encoded by the CASR gene, functions as a G-protein coupled receptor that detects the concentration of calcium ions in the extracellular fluid. When calcium binds to the CaSR protein, it initiates signalling pathways that modulate physiological responses aimed at maintaining calcium balance. In the parathyroid glands, increased calcium binding to CaSR inhibits the production and secretion of parathyroid hormone, which otherwise would raise blood calcium levels. Conversely, reduced calcium binding promotes PTH release.
In the kidneys, CaSR also influences calcium reabsorption. When calcium binds to CaSR in kidney cells, it helps to prevent the reabsorption of calcium, leading to its excretion in the urine. This coordinated action in both parathyroid glands and kidneys underscores the CaSR protein's critical role in systemic calcium regulation.
Video: Genetics 101
Chromosome location
The CASR gene is situated on chromosome 3. Specifically, its chromosomal location is 3q13.33-q21.1. This position indicates that the gene resides on the long arm (q) of chromosome 3, within regions 13.33 to 21.1.
Protein structure
The CASR protein is composed of 1078 amino acids and features several distinct functional regions. The ligand-binding capabilities are primarily attributed to two regions, Ligand-binding 1 (LB1) spanning amino acids 22-188, and Ligand-binding 2 (LB2) from amino acids 189-324. A Cysteine-rich (CR) region is located between amino acids 542-612. Intracellular signalling is facilitated by several loops: Intracellular loop 1 (ICL1) at amino acids 637-648, Intracellular loop 2 (ICL2) from 699-722, and Intracellular loop 3 (ICL3) at 790-805. The C-terminus, located at amino acids 855-1078, also contains specific features including an interaction with RNF19A (amino acids 880-900) and an Arginine-rich retention motif (amino acids 890-898). Furthermore, disordered regions are observed within the C-terminus at amino acids 892-963, 986-1006, and 1030-1055.
Key variants
Variants within the CASR gene can impact the structure and function of the calcium-sensing receptor protein. These genetic changes may alter the protein's ability to bind calcium or to signal effectively, leading to imbalances in calcium homeostasis. The spectrum of variants can range from missense changes to larger deletions, each potentially contributing to different clinical presentations related to calcium dysregulation.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1034dup | p.Asn345fs | Pathogenic/Likely pathogenic | ★★☆☆ | Familial hypocalciuric hypercalcemia |
c.1163C>A | p.Ser388Ter | Pathogenic | ★★☆☆ | Familial hypocalciuric hypercalcemia |
c.1378_1379insAGCAAAGG | - | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal dominant hypocalcemia 1 |
c.1820C>A | p.Ser607Ter | Pathogenic | ★★☆☆ | CASR-related disorder |
c.2011G>T | p.Glu671Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal dominant hypocalcemia 1 |
c.2024G>A | p.Trp675Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Familial hypocalciuric hypercalcemia |
c.2182G>T | p.Val728Phe | Pathogenic/Likely pathogenic | ★★☆☆ | CASR-related disorder |
c.2361CTT[2] | p.Phe790del | Pathogenic | ★★☆☆ | Autosomal dominant hypocalcemia 1 |
c.2440TTC[1] | p.Phe815del | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal dominant hypocalcemia 1 |
c.2486A>G | p.Tyr829Cys | Pathogenic/Likely pathogenic | ★★☆☆ | Nephrolithiasis/nephrocalcinosis |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the CASR gene are associated with several inherited conditions primarily characterised by abnormal calcium levels in the blood. These include Familial hypocalciuric hypercalcaemia, which typically presents with elevated blood calcium and low urinary calcium, and Neonatal severe hyperparathyroidism, a more severe condition caused by biallelic variants that leads to markedly high calcium levels from birth.
Inheritance pattern
Conditions caused by pathogenic CASR variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The CASR gene is included in several panels within the UK's NHS Genomic Medicine Service via PanelApp. It is covered for conditions such as Calcium-sensing receptor phenotypes, Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, Familial hypoparathyroidism, Foetal anomalies, Nephrocalcinosis or nephrolithiasis, Osteogenesis imperfecta, Renal tubulopathies, and Skeletal dysplasia.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary role of the CASR gene?
The CASR gene provides instructions for the calcium-sensing receptor (CaSR) protein, which monitors and regulates calcium levels in the blood. It does this by influencing parathyroid hormone secretion and kidney calcium reabsorption.
What happens if the CASR gene has a pathogenic variant?
Pathogenic variants in the CASR gene can disrupt the normal function of the calcium-sensing receptor, leading to conditions characterised by abnormal calcium levels. Examples include Familial hypocalciuric hypercalcaemia and Neonatal severe hyperparathyroidism.
Where is the CASR gene located?
The CASR gene is located on chromosome 3, specifically at position 3q13.33-q21.1. This indicates its placement on the long arm of chromosome 3.
References
- Kinoshita Y, Hori M, Taguchi M. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia. The Journal of clinical endocrinology and metabolism. 2014. PMID: 24297799
- Thim SB, Birkebaek NH, Nissen PH. Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review. Acta paediatrica (Oslo, Norway : 1992). 2014. PMID: 25039540
- Ranieri M, Tamma G, Di Mise A. Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient. PloS one. 2013. PMID: 24244430
- Raue F, Pichl J, Dörr HG. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey. Clinical endocrinology. 2011. PMID: 21645025
- Hannan FM, Nesbit MA, Christie PT. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Clinical endocrinology. 2010. PMID: 20846291
- Hendy GN, Guarnieri V, Canaff L. Calcium-sensing receptor and associated diseases. Progress in molecular biology and translational science. 2009. PMID: 20374733
- Warner J, Epstein M, Sweet A. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of medical genetics. 2004. PMID: 14985373